Following NLRP3 inflammasome action is the downstream release of DAMPs (i.e., the excess release of nuclear protein high-mobility group box 1 (HMGB1]) through GSDMD, as demonstrated by the hyperinflammation during viral infection and/or COVID-19 [98]. This evidence concerns the gene NLRP3 and COVID-19.